Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
deals
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
2
×
sanofi
2
×
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biontech
biotech
bluerock therapeutics
boehringer ingelheim
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
curevac
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
eli lilly
europe blog main
What
bio
deal
2
×
medicines
acquisitions
announced
bets
cancer
ceo
collabs
comes
companies
covid
cut
daniel
date
effective
enticed
evidence
gilead
gilead’s
hasn’t
help
introduce
ipo
latest
messenger
molecules
month
mrna
multiple
new
o’day
pharmaceutical
plans
primarily
promise
proven
rna
roundup
sanofi
Language
unset
Current search:
sanofi
×
deal
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines